Mechanistically, CD44 antagonizes NK cell internalization by reducing N-cadherin-mediated intercellular adhesion and enhancing Rho GTPase-regulated cell stiffness, and blockade of CD44 signaling results in the suppressive effects of NK cells on tumor growth associated with increased heterotypic CIC formation. The gene discussed is CD44; the disease is neoplasm.